Sema4 Signal Tests Get Approval from New York State
Sema4 Signal PanCancer, with an approximately 2,200-gene panel, delivers a targeted approach to DNA and RNA sequencing for solid and hematologic cancers.
Read MoreSearch Results for: liver disease
Synergy Laboratories Now Able to Test for Covid-19 Antibodies
Synergy is using two newly developed serology testing assays, one produced by Beckman Coulter and another produced by Siemens Healthcare Diagnostics.
Read MoreQuantabio RT-qPCR Kit Gets Expanded Role in CDC Covid-19 Testing Protocol
Public health laboratories facing RNA extraction reagent supply shortages are now advised to use the amended protocol.
Read MoreSimplexa Flu A/B and RSV Direct Gen II Kit Gets CE Mark
More than 100 Flu A, Flu B, and RSV strains have been validated, including the 2020/2021 influenza vaccine strains.
Read More
Blood Tests Can Predict the Risk of Liver Cirrhosis
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease.
Read More